Pembrolizumab trials for Cutaneous Melanoma

All Pembrolizumab trials · All Cutaneous Melanoma trials

Phase breakdown

Recruiting trials studying Pembrolizumab for Cutaneous Melanoma

• A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
  NCT05824975 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 22 locations
• A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
  NCT06624644 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 9 locations
• Neoadjuvant Combination Immunotherapy for Stage III Melanoma
  NCT03842943 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials study Pembrolizumab for Cutaneous Melanoma?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.